Annual CAPEX
$898.00 K
+$101.00 K+12.67%
December 31, 2023
Summary
- As of February 23, 2025, VRDN annual capital expenditures is $898.00 thousand, with the most recent change of +$101.00 thousand (+12.67%) on December 31, 2023.
- During the last 3 years, VRDN annual CAPEX has risen by +$856.00 thousand (+2038.10%).
- VRDN annual CAPEX is now at all-time high.
Performance
VRDN CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
$293.00 K
+$189.00 K+181.73%
September 30, 2024
Summary
- As of February 23, 2025, VRDN quarterly capital expenditures is $293.00 thousand, with the most recent change of +$189.00 thousand (+181.73%) on September 30, 2024.
- Over the past year, VRDN quarterly CAPEX has stayed the same.
- VRDN quarterly CAPEX is now -27.48% below its all-time high of $404.00 thousand, reached on September 30, 2023.
Performance
VRDN Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CAPEX
$445.00 K
-$111.00 K-19.96%
September 30, 2024
Summary
- As of February 23, 2025, VRDN TTM capital expenditures is $445.00 thousand, with the most recent change of -$111.00 thousand (-19.96%) on September 30, 2024.
- Over the past year, VRDN TTM CAPEX has stayed the same.
- VRDN TTM CAPEX is now -58.83% below its all-time high of $1.08 million, reached on September 30, 2023.
Performance
VRDN TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
VRDN CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.7% | 0.0% | 0.0% |
| 3 y3 years | +2038.1% | 0.0% | 0.0% |
| 5 y5 years | +101.8% | 0.0% | 0.0% |
VRDN CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +165.7% | -27.5% | +510.4% | -58.8% | +31.7% |
| 5 y | 5-year | at high | +2038.1% | -27.5% | +2763.6% | -58.8% | +959.5% |
| alltime | all time | at high | >+9999.0% | -27.5% | +2763.6% | -58.8% | >+9999.0% |
Viridian Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $293.00 K(+181.7%) | $445.00 K(-20.0%) |
| Jun 2024 | - | $104.00 K(+116.7%) | $556.00 K(-38.1%) |
| Dec 2023 | $898.00 K(+12.7%) | $48.00 K(-88.1%) | $898.00 K(-16.9%) |
| Sep 2023 | - | $404.00 K(+22.1%) | $1.08 M(+40.0%) |
| Jun 2023 | - | $331.00 K(+187.8%) | $772.00 K(+5.3%) |
| Mar 2023 | - | $115.00 K(-50.2%) | $733.00 K(-8.0%) |
| Dec 2022 | $797.00 K(+135.8%) | $231.00 K(+143.2%) | $797.00 K(+22.6%) |
| Sep 2022 | - | $95.00 K(-67.5%) | $650.00 K(-12.2%) |
| Jun 2022 | - | $292.00 K(+63.1%) | $740.00 K(+47.4%) |
| Mar 2022 | - | $179.00 K(+113.1%) | $502.00 K(+48.5%) |
| Dec 2021 | $338.00 K(+704.8%) | $84.00 K(-54.6%) | $338.00 K(+39.1%) |
| Sep 2021 | - | $185.00 K(+242.6%) | $243.00 K(+118.9%) |
| Jun 2021 | - | $54.00 K(+260.0%) | $111.00 K(+94.7%) |
| Mar 2021 | - | $15.00 K(-236.4%) | $57.00 K(+35.7%) |
| Dec 2020 | $42.00 K(-50.0%) | -$11.00 K(-120.8%) | $42.00 K(-20.8%) |
| Sep 2020 | - | $53.00 K(>+9900.0%) | $53.00 K(-36.9%) |
| Dec 2019 | $84.00 K(-81.1%) | $0.00(-100.0%) | $84.00 K(-37.8%) |
| Sep 2019 | - | $15.00 K(-53.1%) | $135.00 K(-58.5%) |
| Jun 2019 | - | $32.00 K(-13.5%) | $325.00 K(-16.0%) |
| Mar 2019 | - | $37.00 K(-27.5%) | $387.00 K(-13.0%) |
| Dec 2018 | $445.00 K | $51.00 K(-75.1%) | $445.00 K(+4.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | $205.00 K(+118.1%) | $428.00 K(+49.7%) |
| Jun 2018 | - | $94.00 K(-1.1%) | $286.00 K(-3.7%) |
| Mar 2018 | - | $95.00 K(+179.4%) | $297.00 K(+20.7%) |
| Dec 2017 | $246.00 K(+8100.0%) | $34.00 K(-46.0%) | $246.00 K(+16.0%) |
| Sep 2017 | - | $63.00 K(-40.0%) | $212.00 K(+42.3%) |
| Jun 2017 | - | $105.00 K(+138.6%) | $149.00 K(+238.6%) |
| Mar 2017 | - | $44.00 K(>+9900.0%) | $44.00 K(+1366.7%) |
| Dec 2016 | $3000.00(-97.6%) | $0.00(0.0%) | $3000.00(-88.5%) |
| Sep 2016 | - | $0.00(0.0%) | $26.00 K(-55.2%) |
| Jun 2016 | - | $0.00(-100.0%) | $58.00 K(-29.3%) |
| Mar 2016 | - | $3000.00(-87.0%) | $82.00 K(-33.3%) |
| Dec 2015 | $123.00 K(-53.8%) | $23.00 K(-28.1%) | $123.00 K(-66.0%) |
| Sep 2015 | - | $32.00 K(+33.3%) | $362.00 K(+9.7%) |
| Jun 2015 | - | $24.00 K(-45.5%) | $330.00 K(+6.5%) |
| Mar 2015 | - | $44.00 K(-83.2%) | $310.00 K(+16.5%) |
| Dec 2014 | $266.00 K(+5220.0%) | $262.00 K(>+9900.0%) | $266.00 K(+3755.1%) |
| Sep 2014 | - | $0.00(-100.0%) | $6900.00(-23.3%) |
| Jun 2014 | - | $4000.00(+37.9%) | $9000.00(+80.0%) |
| Dec 2013 | $5000.00(-95.3%) | $2900.00(+38.1%) | $5000.00(+138.1%) |
| Sep 2013 | - | $2100.00 | $2100.00 |
| Dec 2012 | $106.90 K | - | - |
FAQ
- What is Viridian Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Viridian Therapeutics?
- What is Viridian Therapeutics annual CAPEX year-on-year change?
- What is Viridian Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Viridian Therapeutics?
- What is Viridian Therapeutics quarterly CAPEX year-on-year change?
- What is Viridian Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for Viridian Therapeutics?
- What is Viridian Therapeutics TTM CAPEX year-on-year change?
What is Viridian Therapeutics annual capital expenditures?
The current annual CAPEX of VRDN is $898.00 K
What is the all time high annual CAPEX for Viridian Therapeutics?
Viridian Therapeutics all-time high annual capital expenditures is $898.00 K
What is Viridian Therapeutics annual CAPEX year-on-year change?
Over the past year, VRDN annual capital expenditures has changed by +$101.00 K (+12.67%)
What is Viridian Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of VRDN is $293.00 K
What is the all time high quarterly CAPEX for Viridian Therapeutics?
Viridian Therapeutics all-time high quarterly capital expenditures is $404.00 K
What is Viridian Therapeutics quarterly CAPEX year-on-year change?
Over the past year, VRDN quarterly capital expenditures has changed by $0.00 (0.00%)
What is Viridian Therapeutics TTM capital expenditures?
The current TTM CAPEX of VRDN is $445.00 K
What is the all time high TTM CAPEX for Viridian Therapeutics?
Viridian Therapeutics all-time high TTM capital expenditures is $1.08 M
What is Viridian Therapeutics TTM CAPEX year-on-year change?
Over the past year, VRDN TTM capital expenditures has changed by $0.00 (0.00%)